Gene · 5734
Papers4,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances. | Int J Med Sci | 2023 | 37790847 | PubTator, text mining | PubMed |
| High CD8+tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma. | Front Immunol | 2023 | 37781365 | PubTator, text mining | PubMed |
| Recent advances in the understanding of cilia mechanisms and their applications as therapeutic targets. | Front Mol Biosci | 2023 | 37780208 | PubTator, text mining | PubMed |
| Macroarray expression analysis of cytokines and prostaglandin metabolism-related genes in chronic rhinosinusitis. | J Allergy Clin Immunol Glob | 2023 | 37779524 | PubTator, text mining | PubMed |
| Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer. | EBioMedicine | 2023 | 37776595 | PubTator, text mining | PubMed |
| Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis. | Front Immunol | 2023 | 37771586 | PubTator, text mining | PubMed |
| Indole-Based and Cyclopentenylindole-Based Analogues Containing Fluorine Group as Potential 18F-Labeled Positron Emission Tomography (PET) G-Protein Coupled Receptor 44 (GPR44) Tracers. | Pharmaceuticals (Basel) | 2023 | 37765011 | PubTator, text mining | PubMed |
| Epidemiologic Study of Gene Distribution in Romanian and Brazilian Patients with Non-Cicatricial Alopecia. | Medicina (Kaunas) | 2023 | 37763773 | PubTator, text mining | PubMed |
| Enamel Matrix Derivative Suppresses Chemokine Expression in Oral Epithelial Cells. | Int J Mol Sci | 2023 | 37762294 | PubTator, text mining | PubMed |
| Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study. | Children (Basel) | 2023 | 37761532 | PubTator, text mining | PubMed |
| The Expression of Trace Amine-Associated Receptors (TAARs) in Breast Cancer Is Coincident with the Expression of Neuroactive Ligand-Receptor Systems and Depends on Tumor Intrinsic Subtype. | Biomolecules | 2023 | 37759760 | PubTator, text mining | PubMed |
| Physiological functions of calcium signaling via Orai1 in cancer. | J Physiol Sci | 2023 | 37759164 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism in health and disease. | MedComm (2020) | 2023 | 37746665 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals distinct tumor microenvironment of ground glass nodules and solid nodules in lung adenocarcinoma. | Front Cell Dev Biol | 2023 | 37745301 | PubTator, text mining | PubMed |
| NETosis: an emerging therapeutic target in renal diseases. | Front Immunol | 2023 | 37744367 | PubTator, text mining | PubMed |
| Emerging principles of primary cilia dynamics in controlling tissue organization and function. | EMBO J | 2023 | 37743763 | PubTator, text mining | PubMed |
| Specific binding of GPR174 by endogenous lysophosphatidylserine leads to high constitutive Gs signaling. | Nat Commun | 2023 | 37737235 | PubTator, text mining | PubMed |
| The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment. | Front Pharmacol | 2023 | 37731742 | PubTator, text mining | PubMed |
| Prostaglandin E2 and myocarditis; friend or foe? | Biochem Pharmacol | 2023 | 37722627 | PubTator, text mining | PubMed |
| In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies. | Oncoimmunology | 2023 | 37720687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5734/papers?page=17